Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

DHS Tan, MW Hull, D Yoong, C Tremblay, P O'byrne… - Cmaj, 2017 - Can Med Assoc
Deborah Yoong reports personal fees from Merck and Gilead Science, outside the submitted
work. Cécile Tremblay reports grants and personal fees from Gilead, Merck, ViiV Healthcare…

[HTML][HTML] Role of the pharmacist in caring for patients with HIV/AIDS: clinical practice guidelines

…, N Sheehan, S Stone, L Sulz, D Yoong - The Canadian journal …, 2012 - ncbi.nlm.nih.gov
Over the past decade, there have been numerous advances in HIV therapy, with 6 drug
classes comprising 24 individual antiretroviral agents now available. For patients who are …

A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz

M Naccarato, D Yoong… - Journal of the International …, 2012 - journals.sagepub.com
Efavirenz (EFV) is primarily metabolized by cytochrome P450 (CYP) 2B6 and to a lesser
extent by CYP3A4. Drugs that significantly inhibit or induce these enzymes would then be …

Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study

D Yoong, AM Bayoumi, L Robinson… - … Open Access Journal, 2018 - cmajopen.ca
Deborah Yoong and Tony Antoniou conceived the project; all authors contributed to designing
the study. Deborah YoongDeborah Yoong and Ahmed Bayoumi wrote the first draft of the …

High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV

SA Morrison, D Yoong, TA Hart, P MacPherson… - PLoS …, 2018 - journals.plos.org
… Competing interests: We have read the journal's policy and the authors of this manuscript
have the following competing interests: Deborah Yoong has received honoraria from Gilead, …

Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis

D Yoong, M Naccarato, M Sharma… - … journal of STD & …, 2016 - journals.sagepub.com
Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but
has the potential to cause harm if not used properly. Pharmacists are well-positioned to …

A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy

M Naccarato, D Yoong, C Kovacs… - Antiviral therapy, 2012 - journals.sagepub.com
The cytochrome P450 isoforms primarily involved in clobazam metabolism are CYP3A4 and
2C19. Drugs that modulate these enzymes would then be expected to alter the exposure of …

Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid

T Antoniou, K Gough, D Yoong… - Clinical Infectious …, 2004 - academic.oup.com
A 42-year-old man with human immunodeficiency virus (HIV) infection and a history of complex
partial seizures developed severe anemia after the addition of valproic acid to his stable …

Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures

M Clifford Rashotte, D Yoong… - … journal of STD & …, 2024 - journals.sagepub.com
PEP-In-Pocket (Post-Exposure Prophylaxis-In-Pocket, or “PIP”) is a biobehavioural HIV
prevention strategy wherein patients are proactively identified and given a prescription for HIV …

Probable hepatotoxicity with dolutegravir: Report of two cases and review of the literature

S Nhean, D Yoong, DK Wong, K Gough, AL Tseng - Aids, 2019 - journals.lww.com
Drug-induced liver injury (DILI) has been described with antiretrovirals including stavudine,
nevirapine, and protease inhibitors [1]. Dolutegravir is a widely used integrase strand-…